For too long, it appeared that for many North American men and their partners who suffered from the effects of erectile dysfunction and Peyronie’s Disease, there was no pathway to healthy sexual function.
Dr. Michael Zahalsky, respected research urologist, author, and founder of Z Urology and UroCellZ, is the first person to conduct an IRB-approved multi-institutional retrospective study on 110 patients regarding the safety, usage and quantity of ProFlo, an amniotic fluid-based biologic treatment for male sexual dysfunction.
Not only has the trail been blazed, but biologics therapy with ProFlo appears to be a proven, safe, and effective expressway to healthy sexual function – even for men with ED or Peyronie’s unresponsive to traditional pharmaceuticals and alternative therapies.
The results of the study, involving University of South Florida, Valley Urologic Associates, Washington Heights Urology, and Z Urology, will be the focus of several events at the November 3-6 meeting of the Sexual Medical Society of North America at the Phoenician in Scottsdale, AZ:
November 3, 2016 – 3:25 pm – 3:30 pm Poster #120 “A Multi-Institutional Retrospective Study on Safety, Usage and Quantity of ProFlo, an
Amniotic Fluid Injectable used in the treatment of Erectile Dysfunction and Peyronie’s Disease.”
November 4, 2016 – 1:45 pm – 2:00 pm Talk: “Advances in Biologics and Stem Cells for Sexual Dysfunction.”
November 4, 2016 – 3:05 pm – 3:10 pm Poster # 168: “The Treatment of Erectile Dysfunction in Men post Radical Prostatectomy with Amniotic Fluid Injection.”
November 5, 2016 – 6:00 pm Panel Discussion & Cocktails “Learn the Truth about Biologics for Urology.”